Urofollitropin is primarily used in women who have difficulty ovulating due to various conditions, making it a cornerstone in infertility therapy. By stimulating the development of multiple ovarian follicles, it helps improve ovulation outcomes and increases the chances of conception. It is commonly used in assisted reproductive technologies (ART), including In Vitro Fertilization (IVF), where it promotes the growth and final maturation of follicles prior to egg retrieval.

In clinical practice, urofollitropin is often combined with other fertility medications, such as Human Chorionic Gonadotrophin (HCG), to optimize ovulation and improve fertility treatment success rates. It is administered under strict medical supervision, as improper use may lead to side effects such as abdominal discomfort, bloating, nausea, vomiting, or headaches. Careful monitoring ensures that the ovarian response is safe and effective.

Since 2013, our team has been manufacturing pharmaceuticals for more than ten years, and we have a solid track record of creating reproductive hormones of the highest caliber. Our 2,523-square-meter production facilities are completely compatible with GMP (Good Manufacturing Practice) standards, guaranteeing a clean and regulated production environment.

To ensure constant safety, purity, and effectiveness, stringent quality control procedures are put in place at every stage, including raw material verification, environmental monitoring, and final product testing. Beyond technical superiority, we place a high priority on client satisfaction by providing thorough technical assistance, complete registration documents, and customized solutions to satisfy specific client needs.